[
    [
        {
            "time": "2021-12-15",
            "original_text": "Mexico approves emergency use of Lilly's COVID-19 treatment",
            "features": {
                "keywords": [
                    "Mexico",
                    "approves",
                    "emergency use",
                    "Lilly's",
                    "COVID-19",
                    "treatment"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Mexico approves emergency use of Lilly's COVID-19 treatment",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2022-01-10",
            "original_text": "Lilly to Announce Initial 2022 Financial Guidance; Provide R&D Overview at Investment Community Meeting",
            "features": {
                "keywords": [
                    "Lilly",
                    "Financial Guidance",
                    "R&D",
                    "Investment Community Meeting"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly to Announce Initial 2022 Financial Guidance; Provide R&D Overview at Investment Community Meeting",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-30",
            "original_text": "Merck (MRK) Up as COVID Pill Gets FDA Panel's Positive Vote",
            "features": {
                "keywords": [
                    "Merck",
                    "COVID Pill",
                    "FDA Panel",
                    "Positive Vote"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Merck (MRK) Up as COVID Pill Gets FDA Panel's Positive Vote",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]